Article

June is Cataract Awareness Month

Prevent Blindness America (PBA) has declared June as Cataract Awareness Month in an effort to educate the public on the risk factors, symptoms, and treatment options of the world?s leading cause of blindness.

Chicago-Prevent Blindness America (PBA) has declared June as Cataract Awareness Month in an effort to educate the public on the risk factors, symptoms, and treatment options of the world’s leading cause of blindness.

According to PBA, there are more cases of cataract globally than there are of glaucoma, age-related macular degeneration, and diabetic retinopathy combined. Today, cataract affects more than 22 million Americans aged 40 and older. As the U.S. population ages, more than 30.1 million Americans are projected to have cataracts by the year 2020.

Risk factors for developing cataract include a family history of cataract, diabetes, smoking, extended exposure to UV rays, serious eye injury, and the use of steroids.

Americans spend $6.8 billion every year on direct medical costs for outpatient, inpatient, and prescription drug services for cataracts, according to “Economic Impact of Vision Problems: The Toll of Major Adult Eye Disorders, Visual Impairment, and Blindness on the U.S. Economy,” a 2007 study funded by PBA.

“We encourage everyone, especially those age 40 and over, to get a dilated, baseline eye exam from [their] eye care professional,” said Hugh R. Parry, PBA’s president and CEO.

PBA offers free information on cataracts in both English and Spanish, as well as the fact sheets Your Guide to Cataract Surgery and Medicare Benefits and Your Eyes. Call 800/331-2020 or visit www.preventblindness.org.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.